Dashboard
Transactions
Sign in
Create account
← All stocks
TELA Bio, Inc.
TELA
Net buying
CIK 0001561921
#4919 in the set
updated 17 Sep 2026
1 month
12 months
120 months
Bought (1 mo)
$86.75K
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$86.75K
+$86.75K against sales at will
By person
19 insiders · 3 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Capper Joseph H
Director
$78.44K
(2)
—
+$78.44K
104,827
0.2335%
$110.99K
—
Getz Heather C
Chief Executive Officer
$8.31K
(1)
—
+$8.31K
532,500
1.19%
$563.81K
+10,550%
EW HEALTHCARE PARTNERS FUND 2, L.P.
entity
10% owner
—
—
—
7,714,709
17.18%
$8.17M
+87.7%
KOBLISH ANTONY
Chief Executive Officer
—
—
—
586,210
1.31%
$620.68K
+168.7%
Cuca Roberto
COO and CFO
—
—
—
257,377
0.5733%
$272.51K
+173.3%
Blizard Jeffrey
President
—
—
—
205,125
0.4569%
$217.19K
+3,118%
Talmo Paul
Chief Technology Officer
—
—
—
173,436
0.3863%
$183.63K
+151.9%
Firestone Gregory A.
Chief Business Officer
—
—
—
139,307
0.3103%
$147.50K
+164.1%
Smeykal Megan
Chief Accounting Officer
—
—
—
66,873
0.1490%
$70.81K
+122.3%
Plovanic William J.
Director
—
—
—
44,530
0.0992%
$47.15K
—
THOMAS PAUL
Director
—
—
—
23,600
0.0526%
$24.99K
—
NEELS GUIDO J
Director
—
—
—
23,600
0.0526%
$24.99K
—
NOHRA GUY P
Director
—
—
—
23,600
0.0526%
$24.99K
—
Rocchio Betty Jo
Director
—
—
—
23,600
0.0526%
$24.99K
—
Burgess Vincent J
Director
—
—
—
23,330
0.0520%
$24.70K
+51.7%
O'Brien Federica F.
Director
—
—
—
18,470
0.0411%
$19.56K
+75.6%
EVANS DOUGLAS G
Director
—
—
—
18,470
0.0411%
$19.56K
+75.6%
Azarbarzin Kurt
Director
—
—
—
18,470
0.0411%
$19.56K
+75.6%
COLLERAN LISA N
Director
—
—
—
18,470
0.0411%
$19.56K
+75.6%
Individual transactions
0
Everything
Bought
Sold at will
On a plan
Out of an exercise
Exercised, kept
Nothing of that kind in this period.
What was left out
Form 4 filings counted
3
Amendments (4/A) skipped
0
Filings about a different issuer
0
Unreadable filings
0
Joint filings
0
Sales on a Rule 10b5-1 plan
0
Sales straight out of an exercise
0
Sales at will
0
Transactions with no price
0
Shares from compensation/vesting
0
History held since
13 Nov 2019